Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRVS
KURA
Add up to 3 more stocks
CRVS
Corvus Pharmaceuticals, Inc.
-1.68%
$10.56-0.18Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$887.99M
52W Range
$6.39 - $26.95
KURA
Kura Oncology, Inc.
-0.85%
$10.53-0.09Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$934.79M
52W Range
$7.36 - $13.90
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.94 | 19.30 |
| P/S Ratio | N/A | 12.10 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 94.7% |
| Operating Margin | 0.0% | -449.9% |
| Net Margin | 0.0% | -384.3% |
| ROE | -24.0% | -612.8% |
| ROA | -22.6% | -50.5% |
| ROIC | -25.3% | -67.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.16 | 4.73 |
| Quick Ratio | 16.16 | 4.71 |
| Debt/Equity | 0.00 | 0.50 |
| Interest Coverage | N/A | -200.81 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.